alexa Discovery Of Novel Lead Compounds By Large Scale Diverse Encoded Chemical Libraries
ISSN: 2161-0444

Medicinal chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Jin Li
ScientificTracks Abstracts: Med Chem
DOI: 10.4172/2161-0444.S1.011
In this talk, the author will present the design strategy in building a highly diverse, three dimensional and drug-like DNA encoded libraries (DELs) to facilitate lead-finding for novel protein target families. Library synthesis methodologies that facilitate incorporation of linking chemistry compatible with DNA integrity will be presented. Computational analysis of the resultant libraries? molecular properties will be shown. Validation of affinity screening, coding and decoding processes to identify known and novel enzyme inhibitors will be described, along with our early results in affinity screening of this library of >400 million compounds with highly validated protein targets from several protein families.
Jin Li holds 26 years of biopharmaceutical experience (at Protherics and AstraZeneca), with scientific and leadership roles in early stage research; as well as experience in initiating and leading major collaboration and outsourcing programmes. Before founding HitGen, he held Global Director position of Compound Sciences and Computational Sciences at AstraZeneca. This included responsibility for computational chemistry, computational biology and compound collection enhancement for lead generation. He completed his BSc at Sichuan University, and PhD in Macromolecular Sciences at Aston University. Then he completed Postdoctoral research in Theoretical Biochemistry at Manchester University, UK.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version